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Purpose of the study
Most guidelines advise to organize follow-up of chroni-
cally HIV-infected patients every 3 to 4 months. However,
each year patients disappear from care and are lost to fol-
low-up (LTFU). This study describes LTFU in a population
of HIV-infected patients followed at a reference outpatient
clinic in Antwerp, Belgium.
Methods
Patients were considered LTFU if they did not come back
for one calendar year after their last visit. Patient who
received HAART were included. Patients who only came
once to the consultation were excluded. The Student's
unpaired t-, Mann-Whitney U- and chi-square tests were
used in the statistical analysis.
Summary of results
1,302 HAART-treated patients came at least twice to the
consultation in the period 2000–2006 and were included
in this study. The total number of consultations through-
out the study period was 29,500. A total of 289 patients
(22.2%) were out of care for at least one year during this
period. Of these, 47 died (3.6%) and 31 went to another
hospital (2.4%); the remainder (n = 211; 16.2%) were
LTFU. The average LTFU rate was 2.3/100 patients/year
and remained stable across the years. The LTFU patients
were more often heterosexual and intravenous drug users
(IVDU). Moreover, they were more often uncovered by
health insurance and were living outside the province of
Antwerp. They had more often detectable viral loads on
their last visit, were longer in care, and had fewer follow-
up visits on average per year. The first HAART regimen was
shorter among LTFU patients. Ethnic origin, gender, base-
line CD4 count, hepatitis C status, total length of treat-
ment, and language spoken were not significantly
associated with LTFU.
Conclusion
Patients without health insurance, having to travel longer
distance to reach the clinic, and IVDU users are at risk for
LTFU. Such patients should be the target of reinforced
counseling and follow-up. The LTFU patients frequently
disappeared from care with a detectable viral load with
the risk of further spread of potentially resistant virus.
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